<code id='85407DA918'></code><style id='85407DA918'></style>
    • <acronym id='85407DA918'></acronym>
      <center id='85407DA918'><center id='85407DA918'><tfoot id='85407DA918'></tfoot></center><abbr id='85407DA918'><dir id='85407DA918'><tfoot id='85407DA918'></tfoot><noframes id='85407DA918'>

    • <optgroup id='85407DA918'><strike id='85407DA918'><sup id='85407DA918'></sup></strike><code id='85407DA918'></code></optgroup>
        1. <b id='85407DA918'><label id='85407DA918'><select id='85407DA918'><dt id='85407DA918'><span id='85407DA918'></span></dt></select></label></b><u id='85407DA918'></u>
          <i id='85407DA918'><strike id='85407DA918'><tt id='85407DA918'><pre id='85407DA918'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:33572
          Photo illustration of a checkbook wrapped with lock and chain – hospital and investment coverage from STAT
          Alex Hogan/STAT

          Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back.

          NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office — a spokesperson described it as being “integrated” into the broader strategy. PitchBook data show no investments after 2020.

          advertisement

          Advocate Health Enterprises, meanwhile, the venture firm of a 67-hospital system based in Charlotte, N.C., has lost at least six employees within the past year, including its president, from a staff that once included about a dozen people.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Pharma showers House GOP doctor with campaign cash
          Pharma showers House GOP doctor with campaign cash

          Rep.LarryBucshon(R-Ind.)receivedasignificantamountofcampaigndonationsfromthepharmaceuticalindustryin

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

          1:03JackSmith,thentheDepartmentofJustice'schiefofthePublicIntegritySection,posesforphotoattheDepartm